- Filed
- Feb 24, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Feb 18, 2026 | 37.65M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 41.1M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 44.52M sh |
| Shares Diluted | FY 2025 · Dec 31, 2023 | 46.46M sh |
| Stock Repurchased | FY 2025 · Dec 31, 2025 | $173.79M |
| Stock Repurchased | FY 2025 · Dec 31, 2024 | $185.18M |
| Stock Repurchased | FY 2025 · Dec 31, 2023 | $108.53M |
| Capex | FY 2025 · Dec 31, 2025 | $119.2M |
| Capex | FY 2025 · Dec 31, 2024 | $106.64M |
| Capex | FY 2025 · Dec 31, 2023 | $108.73M |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | $407.07M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | $390.32M |
| Operating Cash Flow | FY 2025 · Dec 31, 2023 | $319.96M |
| Long Term Debt | FY 2025 · Dec 31, 2025 | $717.82M |
| Long Term Debt | FY 2025 · Dec 31, 2024 | $864.28M |
| Short Term Debt | FY 2025 · Dec 31, 2025 | $148.69M |
| Short Term Debt | FY 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $607.01M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $505.88M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $1.75B |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $1.81B |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $1.89B |
| Stockholders Equity | FY 2025 · Dec 31, 2022 | $1.89B |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $1.07B |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $899.65M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $1.91B |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $1.89B |
| Current Assets | FY 2025 · Dec 31, 2025 | $1.37B |
| Current Assets | FY 2025 · Dec 31, 2024 | $1.27B |
| Total Assets | FY 2025 · Dec 31, 2025 | $3.66B |
| Total Assets | FY 2025 · Dec 31, 2024 | $3.7B |
| Eps Diluted | FY 2025 · Dec 31, 2025 | $1.15 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | $1.42 |
| Eps Diluted | FY 2025 · Dec 31, 2023 | $0.89 |
| Eps Basic | FY 2025 · Dec 31, 2025 | $1.16 |
| Eps Basic | FY 2025 · Dec 31, 2024 | $1.42 |
| Eps Basic | FY 2025 · Dec 31, 2023 | $0.89 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $210.03M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $203.46M |
| Sga Expense restated | FY 2025 · Dec 31, 2023 | $195.73M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $61.96M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $67.37M |
| Rd Expense | FY 2025 · Dec 31, 2023 | $68.86M |
| Net Income | FY 2025 · Dec 31, 2025 | $47.35M |
| Net Income | FY 2025 · Dec 31, 2024 | $63.05M |
| Net Income | FY 2025 · Dec 31, 2023 | $41.5M |
| Operating Income | FY 2025 · Dec 31, 2025 | $183.09M |
| Operating Income | FY 2025 · Dec 31, 2024 | $113.65M |
| Operating Income | FY 2025 · Dec 31, 2023 | $132.61M |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $206.6M |
| Cost Of Revenue | FY 2025 · Dec 31, 2024 | $200.32M |
| Cost Of Revenue restated | FY 2025 · Dec 31, 2023 | $185.65M |
| Revenue | FY 2025 · Dec 31, 2025 | $1.45B |
| Revenue | FY 2025 · Dec 31, 2024 | $1.4B |
| Revenue | FY 2025 · Dec 31, 2023 | $1.36B |